Consolidation of India’s Takshasila Hospitals and its contribution to revenue
First written in FY2017-Q3. 12 of 13 entries say "Restated". Latest entry: FY2027-H1.
No other company in this theme has enough history to compare yet.
- FY2027-H1RestatedAnnual report
「In the medical services business, revenue was ¥48.4 billion, up 7.6% year on year, due to strong sales of medical equipment and higher revenue at Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator, among other factors,」
Higher revenue at the Indian general hospital operator has continued to contribute, together with strong sales of medical equipment. - FY2026RestatedAnnual report
「In the consolidated fiscal year under review, revenue increased 6.8% year on year to ¥92.0 billion, due to strong sales of medical devices and pharmaceuticals and higher revenue from Takshashila Hospitals Operating Pvt. Ltd., a general hospital operator in India, among other factors. Operating income increased 15.6% to ¥6.2 billion.」
Higher revenue at the Indian general hospital operator has continued to contribute, together with strong sales of medical equipment and pharmaceuticals. - FY2026-H1RestatedAnnual report
「In the medical services business, revenue was ¥45.0 billion, up 5.9% year on year, due to strong sales of medical devices and pharmaceuticals and higher revenue from Takshashila Hospitals Operating Pvt. Ltd., a general hospital operator in India, among other factors. Operating income increased 20.8% to ¥3.2 billion.」
Higher revenue at the Indian general hospital operator Takshasila Hospitals has continued to contribute, together with strong sales of medical equipment and pharmaceuticals. - FY2024RestatedAnnual report
「In the consolidated fiscal year, higher revenue at Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator, and strong pharmaceutical sales, among other factors, resulted in revenue of ¥80.1 billion, up 3.2% year on year,」
Higher revenue at the Indian general hospital operator has continued to contribute to higher revenue in the medical services business, together with strong pharmaceutical sales. - FY2024-Q3RestatedAnnual report
「In the medical services business, revenue was ¥60.0 billion, up 3.7% year on year, due to higher revenue at Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator, and strong pharmaceutical sales, among other factors, while operating profit was ¥4.8 billion, up 5.4% year on year.」
Higher revenue at the Indian general hospital operator has continued to contribute to higher revenue and operating profit in the medical services business, together with strong pharmaceutical sales. - FY2024-Q2RestatedAnnual report
「In the medical services business, revenue was ¥38.9 billion, up 2.9% year on year, due to higher revenue at Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator, and strong pharmaceutical sales, among other factors, while operating profit was ¥3.2 billion, up 11.0% year on year.」
Higher revenue at the Indian general hospital operator has continued to contribute to higher revenue and operating profit in the medical services business, together with strong pharmaceutical sales. - FY2024-Q1RestatedAnnual report
「In the medical services business, revenue was ¥19.2 billion, up 6.7% year on year, due to strong sales of medical equipment and pharmaceuticals and higher revenue at Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator, among other factors, while operating profit was ¥1.6 billion, up 17.4% year on year.」
Higher revenue at the Indian general hospital operator has continued to contribute to higher revenue and operating profit in the medical services business, together with strong sales of medical equipment and pharmaceuticals. - FY2023-Q3RestatedAnnual report
「In the medical services business, revenue was ¥57.9 billion, up 4.3% year on year, due to strong sales of medical devices and higher revenue from Takshashila Hospitals Operating Pvt. Ltd., a general hospital operator in India, among other factors. Operating income increased 8.8% to ¥4.5 billion.」
Higher revenue at the Indian general hospital operator Takshasila Hospitals has continued to contribute to performance in the medical services business. - FY2023-Q2RestatedAnnual report
「In the medical services business, revenue was ¥37.8 billion, up 4.3% year on year, due to higher sales of medical consumables and higher revenue from Takshashila Hospitals Operating Pvt. Ltd., a general hospital operator in India, among other factors. Operating income increased 6.7% to ¥2.8 billion.」
Higher revenue at the Indian general hospital operator Takshasila Hospitals has continued to contribute to performance in the medical services business. - FY2023-Q1RestatedAnnual report
「In the medical services business, revenue was ¥18.0 billion, up 0.1% year on year, due to higher revenue from Takshashila Hospitals Operating Pvt. Ltd., a general hospital operator in India, among other factors. Operating income increased 4.6% to ¥1.3 billion.」
Higher revenue at the Indian general hospital operator Takshasila Hospitals has continued to contribute to performance in the medical services business. - FY2022RestatedAnnual report
「In the consolidated fiscal year, increased sales of medical consumables and higher revenue at Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator, among other factors, led to」
Higher revenue at the Indian general hospital operator has continued to contribute to full-year performance in the medical services business. - FY2022-Q2RestatedAnnual report
「In the medical services business, revenue was ¥36.2 billion, up 3.4% year on year, due to increased sales of medical consumables and higher revenue at Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator, among other factors,」
Higher revenue at the Indian general hospital operator Takshasila Hospitals has continued to contribute to performance in the medical services business. - FY2017-Q3First statedAnnual report
「The contribution of Takshasila Hospitals Operating Pvt. Ltd., an Indian general hospital operator newly included as a consolidated subsidiary, also contributed」
The disclosure first states that an Indian general hospital operator became a new consolidated subsidiary and contributed to revenue in the medical services business.